Open Access839 Response and Healthcare Resource Utilization in Inflammatory Bowel Disease Patients Treated With Either Infliximab or Vedolizumab
Author(s) -
H Sarles,
Thomas C. Hardin,
Samantha A. Kuten,
Lucinda J. Van Anglen
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000592892.03021.99
Subject(s) - vedolizumab , medicine , infliximab , inflammatory bowel disease , ulcerative colitis , adverse effect , demographics , crohn's disease , disease , gastroenterology , demography , sociology